Market Overview

UPDATE: Goldman Sachs Downgrades Standard Motor Products on Likely Earnings Growth Deceleration


In a report published Tuesday, Goldman Sachs analyst Patrick Archambault downgraded Standard Motor Products (NYSE: SMP) to Sell, but reiterated the $34.00 price target.

In the report, Goldman Sachs noted, “We downgrade Standard Motor Products to Sell with 9% downside to our six month price target of $34 vs. 10% average upside for our coverage. The company has exhibited solid operational execution and successfully integrated a number of acquisitions over the last 12 months and the shares have risen 206% since the June 2012 trough (vs. the S&P up 28%). However, this has driven Standard Motor's NTM P/E to 15.5x from 7.6x, which is approximately 30% above peers even though we see the company sitting at the bottom of our stock ranking framework based on growth, expectations, and end market positioning. Our 2013 and 2014 EPS estimates of $2.22 and $2.45 are 2% and 3% below consensus, respectively, relative to mid-single digit upside across our sector.”

Standard Motor Products closed on Monday at $37.64.

Latest Ratings for SMP

Aug 2016MaintainsBuy
Apr 2016Initiates Coverage onBuy
Feb 2016MaintainsBuy

View More Analyst Ratings for SMP
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Patrick ArchambaultAnalyst Color Downgrades Analyst Ratings


Related Articles (SMP)

View Comments and Join the Discussion!

Latest Ratings

CHNGInitiates Coverage On19.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPDATE: Cowen and Company Downgrades Meridian Bioscience on Tough Road Ahead

UPDATE: Goldman Sachs Downgrades Tenneco Following Removal on Valuation